CorMedix (CRMD) Net Income towards Common Stockholders (QoQ) (2010 - 2025)
CorMedix (CRMD) Net Income towards Common Stockholders (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CorMedix | 4.95 Mn | -150.26 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -110.85% |
| Sep 30, 2025 | 396.58% |
| Jun 30, 2025 | 5.87% |
| Mar 31, 2025 | 53.32% |
| Dec 31, 2024 | 583.98% |
| Sep 30, 2024 | 80.33% |
| Jun 30, 2024 | 2.21% |
| Mar 31, 2024 | 1.95% |
| Dec 31, 2023 | -51.41% |
| Sep 30, 2023 | 13.56% |
| Jun 30, 2023 | -6.68% |
| Mar 31, 2023 | -28.73% |
| Dec 31, 2022 | -19.77% |
| Sep 30, 2022 | -190.18% |
| Jun 30, 2022 | 8.57% |
| Mar 31, 2022 | 172.41% |
| Dec 31, 2021 | -212.41% |
| Sep 30, 2021 | 86.96% |
| Jun 30, 2021 | -36.11% |
| Mar 31, 2021 | 118.98% |